RAS

NEW YORK — September 28, 2026 Immuneering Corporation presented new data at the 2026 AACR Conference on Pancreatic Cancer...

Indianapolis, Indiana, and Cambridge, Massachusetts, August 31, 2026 Eli Lilly and Company and Merida Biosciences, Inc. announced a definitive...

Detroit, Michigan, August 31, 2026 The Barbara Ann Karmanos Cancer Institute announced that it is now offering FDA-approved daraxonrasib...

NEW YORK – August 26, 2026 Immuneering Corporation (Nasdaq: IMRX) highlighted its continued focus on first-line metastatic pancreatic cancer...

REDWOOD CITY, Calif., July 7, 2026 Revolution Medicines has announced a major regulatory milestone as the European Medicines Agency...